Elevated plasma vasopressin and normal cerebrospinal fluid angiotensin-converting enzyme in chronic pain disorder

Biological Psychiatry

Volumn 40, Issue 10, 1996, Pages 994-999

  Wahlbeck, Kristian ^a,b   Sundblom, Markus ^a   Kalso, Eija ^a   Tigerstedt, Irma ^a   Rimón, Ranan ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Department of Psychiatry ^*  (Finland)

Author keywords

angiotensin converting enzyme; arginine vasopressin; cerebrospinal fluid; cigarette smoking; osmolality; pain disorder

Indexed keywords

ANGIOTENSIN; VASOPRESSIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PAIN; PRIORITY JOURNAL; STRESS;

EID: 0030588917     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00577-3     Document Type: Article

References (40)

1. Almay BGL (1987): Patients with idiopathic pain syndromes. PhD Thesis. Umeå University.
2. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association.
3. Anonymous (1992): International Symposium on Substance P and Related Peptides: Pain, Inflammation, Visceral and CNS Functions. Proceedings. Shizuoka, Japan, November 3-6, 1992. Regul Pept 46:1-471.
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961): An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
5. Beckmann H, Saavedra JM, Gattaz WF (1984): Low angiotensin-converting enzyme activity (Kininase II) in cerebrospinal fluid of schizophrenics. Biol Psychiatry 19:679-684.
6. Berson BS, Bernston GG (1980): Antinociceptive effect of intraventricular or systemic administration of vasopressin in the rat. Life Sci 26:455-459.
7. Carr DB, Lipkowski AW (1990): Neuropeptides and pain. Agressologie 31:173-177.
8. Coiro V, Chiodera P (1991): Naloxone increases the angiotensin II stimulated rise of vasopressin and oxytocin secretion in man. Neuroendocrinology 53:209-213.
9. de Goeij DCE, Dijkstra H, Tilders FJH (1992a): Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: Relationship to subordinate status. Endocrinology 131:847-853.
10. de Goeij DCE, Jezova D, Tilders FJH (1992b): Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577:165-168.
11. Derogatis LR, Lipman RS, Covi L (1973): SCL-90: An outpatient psychiatric rating scale - Preliminary report. Psychopharmacol Bull 9:13-28.
12. de Wied D, Diamant M, Fodor M (1993): Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 14:251-302.
13. Dray A, Perkins M (1993): Bradykinin and inflammatory pain. Trends Neurosci 16:99-104.
14. Fyhrquist F, Wallenius M, Hollemans HJG (1976): Radioimmunoassay of vasopressin in unextracted plasma. Scand J Clin Lab Invest 36:841-847.
15. Fyhrquist F, Tikkanen I, Grönhagen-Riska C, Hortling L, Hichens M (1984): Inhibitor binding assay for angiotensin-converting enzyme. Clin Chem 30:696-700.
16. Gehlert DR, Speth RC, Wamsley JK (1986): Distribution of [125I]angiotensin II binding sites in the rat brain: A quantitative autoradiographic study. Neuroscience 18:837-856.
17. Gennari FJ (1984): Serum osmolality. Use and limitations. N Engl J Med 310:102-105.
18. Gjerris A, Hammer M, Vendsborg P, Christensen NJ, Rafaelsen OJ (1985): Cerebrospinal fluid vasopressin - Changes in depression. Br J Psychiatry 147:696-701.
19. Gold PW, Ballenger JC, Robertson GL, et al (1984): Vasopressin in affective illness: Direct measurement, clinical trials and response to hypertonic saline. In Post RM, Ballenger JC (eds), Neurobiology of Mood Disorders. Baltimore: Williams and Wilkins, pp 323-339.
20. Guilford JP (1954): Psychometric Methods. New York: McGraw-Hill.
21. Hasegawa Y, Kitani Y, Sugaya T, Nakajima S, Fujita T (1987): Mechanism of the antinociceptive effect by intracerebroventricular administration of arginin-vasopressin in the monkey. Pain 4(suppl):S51.
22. Haulica I, Neamtu C, Stratone A, et al (1986): Evidence for the involvement of cerebral renin-angiotensin system (RAS) in stress analgesia. Pain 27:237-245.
23. Herman JP, Sherman TG (1993): Acute stress upregulates vasopressin gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Ann N Y Acad Sci 689:546-549.
24. Keil LC, Rosella-Dampman LM, Emmert S, Chee O, Summy-Long JY (1984): Enkephalin inhibition of angiotensin-stimulated release of oxytocin and vasopressin. Brain Res 297: 329-336.
25. Lamelle M, Seghers A, Goffinet S, Bouchez S, Legros JJ (1990): Plasmatic vasopressin neurophysin in depression: Basic levels and relations with HPA axis. Biol Psychiatry 27:1249-1263.
26. Mendelsohn FAO, Quirion R, Saavedra JM, Aguilera G, Catt KJ (1984): Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81:1575-1579.
27. Oksanen V, Fyhrquist F, Somer H, Grönhagen-Riska C (1985): Angiotensin converting enzyme in cerebrospinal fluid: A new assay. Neurology 35:1220-1223.
28. Spitzer RL, Williams JBW, Gibbon M, First MB (1988): Structured Clinical Interview for DSM-III-R - Patient Version (SCID-P 4/1/88). New York: Biometrics Research Department, New York State Psychiatric Institute.
29. Spitzer WO, Dobson AJ, Hall J, et al (1981): Measuring quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis 34:585-597.
30. Sundblom DM, Haikonen S, Niemi-Pynttäri J, Tigerstedt I (1994): Effect of spiritual healing on chronic idiopathic pain: A medical and psychological study. Clin J Pain 10:296-302.
31. Terenius L, Nyberg F (1988): Neuropeptide-processing, -converting, and -inactivating enzymes in human cerebrospinal fluid. Int Rev Neurobiol 30:101-121.
32. Thurston CL, Campbell IG, Culhane ES, Carstens E, Watkins LR (1992): Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression. Peptides 13:17-25.
33. Waeber B, Schaller MD, Nussberger J, Bussien JP, Hofbauer KG, Brunner HR (1984): Skin blood flow reduction induced by cigarette smoking: Role of vasopressin. Am J Physiol 247:H895-H901.
34. Wahlbeck K, Rimón R, Fyhrquist F (1993): Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients. Schizophr Res 9:77-82.
35. Welches WR, Brosnihan KB, Ferrario CM (1993): A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 52:1461-1480.
36. Wiegant VM, Sweep CGJ, Barna I, Veldhuis HD, De Wied D (1989): Involvement of vasopressin in the regulation of the brain proopiomelanocortin system. In Genazzani AR, Negri M (eds), Opioid Peptides in Biological Fluids. Carnforth: Parthenon, pp 25-32.
37. Wright JW, Harding JW (1992): Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Rev 17:227-262.
38. Yien HW, Chan JYH, Tsai HF, Lee TY, Chan SHH (1993): Participation of nucleus reticularis gigantocellularis in the antinociceptive effect of angiotensin III in the rat. Neurosci Lett 159:9-12.
39. Zhang RX, Mi ZP, Qiao JT (1994): Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 51:25-32.
40. Zubenko S, Volicer L, Direnfeld LK, Freeman M, Langlais PJ, Nixon RA (1985): Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. Brain Res 328:215-221.